Cargando…
Pembrolizumab-induced Myasthenia Gravis Relapse after Immunosuppressive Therapy
Myasthenia gravis (MG) is an immune-related adverse event (irAE), and as an irAE, MG (irAE-MG) generally has a monophasic course, with only a few case reports of irAE-MG flare-ups during the course of the disease. We herein report a case of pembrolizumab-induced MG with relapsing symptoms. irAE-MG i...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Japanese Society of Internal Medicine
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683818/ https://www.ncbi.nlm.nih.gov/pubmed/35400705 http://dx.doi.org/10.2169/internalmedicine.8554-21 |